Company profile for Hetero Biopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

As a part of the Hetero Group, our Biologics vertical, comes with a rich legacy - Proven capabilities in the development, manufacturing and marketing of chemical intermediates, APIs, ARVs and Finished Dosage Formulations. With leadership in chemical therapeutics, Hetero continues to lead from the front in the development and manufacturing of Biopharmaceuticals using novel technologies. Hetero has 36 state-of-the-art manufa...
As a part of the Hetero Group, our Biologics vertical, comes with a rich legacy - Proven capabilities in the development, manufacturing and marketing of chemical intermediates, APIs, ARVs and Finished Dosage Formulations. With leadership in chemical therapeutics, Hetero continues to lead from the front in the development and manufacturing of Biopharmaceuticals using novel technologies. Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide. And a majority of our facilities have been successfully audited and approved by stringent regulatory authorities like US FDA, EU, TGA-Australia, MCC-South Africa

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
India
Address
Address
#8-3-166/1 & 2, 105 to 108, 1st Floor, G Block, East Wing, Challa Estates, Err...
Telephone
Telephone
+91 40 23704923
Linkedin
Linkedin
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/pharma/indian-generic-makers-poised-sell-40-versions-gileads-hiv-prep-yeztugo-through-deals-gates

FIERCE PHARMA
24 Sep 2025

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/johnson-johnson-sells-its-largest-india-plant-as-demand-weakens/articleshow/94926683.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

ECONOMICTIMES
18 Oct 2022

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/hetero-acquires-johnson-johnsons-manufacturing-plant-in-telangana/articleshow/94914520.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

ECONOMICTIMES
17 Oct 2022
Hetero Biopharma asked to submit more data on Sputnik Light
Hetero Biopharma asked to submit more data on Sputnik Light

16 Feb 2022

// Teena Thacker ECONOMIC TIMES

https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/hetero-asked-to-submit-more-data-on-sputnik-light/articleshow/89600216.cms

Teena Thacker ECONOMIC TIMES
16 Feb 2022

https://www.pharmacompass.com/pdf/news/hetero-labs-limited-on-health-canada-inspection-list-1641880328.pdf

HEALTH CANADA
08 Jan 2022

https://theprint.in/economy/pharma-firms-to-roll-out-anti-covid-pill-shortly-as-dcgi-approves-emergency-use/790217/

THEPRINT
28 Dec 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty